Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 known ✓ | Q99720 | 5/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.34 |
| ▸ | EPHX1 | P07099 | 3/20 | 0.33 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.33 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL9702003 | 1.00 | LMNA (0.45) | LMNAZDHHC7SIGMAR1EPHX1SLC2A1 | |
| Hydrochloric Acid SCHEMBL10389451 | 1.00 | LMNA (0.45) | LMNAZDHHC7SIGMAR1EPHX1SLC2A1 | |
| SCHEMBL1123235 | 0.98 | LMNA (0.46) | LMNAZDHHC7SIGMAR1EPHX1SLC2A1 | |
| SCHEMBL23754206 | 0.88 | LMNA (0.39) | LMNASIGMAR1 | |
| Hydrochloric Acid SCHEMBL23754229 | 0.85 | LMNA (0.44) | LMNAZDHHC7EPHX1SLC2A1 | |
| SCHEMBL1929523 | 0.83 | LMNA (0.43) | LMNAZDHHC7EPHX1SLC2A1 | |
| Cyanamide SCHEMBL18335593 | 0.83 | LMNA (0.35) | LMNA | |
| SCHEMBL17114245 | 0.83 | LMNA (0.38) | LMNAZDHHC7SIGMAR1EPHX1 | |
| SCHEMBL28823234 | 0.82 | LMNA (0.47) | LMNAZDHHC7EPHX1PLA2G2A | |
| SCHEMBL25206254 | 0.81 | LMNA (0.36) | LMNASIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11130908-B2 | Coated proppants and nanites and methods of making and use of coated proppants and nanites | GROUP HOLDINGS, LLC (US) | 2021-09-28 | — | — | US | claimed |
| US-10196559-B1 | Coated proppants and nanites and methods of making and use of coated proppants and nanites | GROUP HOLDINGS, LLC (US) | 2019-02-05 | — | — | US | claimed |
| US-20180028952-A1 | Ballast Water Treatment Systems | PETERSON II WILLIAM R (US) | 2018-02-01 | — | — | US | claimed |
| US-20180008920-A1 | Ballast Water Treatment Systems | Nano Global Corp. (US) | 2018-01-11 | — | — | US | claimed |
| US-9764264-B2 | Ballast water treatment systems | BERMAN, RENEE | 2017-09-19 | — | — | US | claimed |
| US-20160287717-A1 | Core and Surface Modification of Mesoporous Silica Nanoparticles to Achieve Cell Specific Targeting In Vivo. | STC UNM (US) | 2016-10-06 | — | — | US | claimed |
| EP-3046547-A1 | CORE AND SURFACE MODIFICATION OF MESOPOROUS SILICA NANOPARTICLES TO ACHIEVE CELL SPECIFIC TARGETING IN VIVO | STC.UNM (US) | 2016-07-27 | — | — | EP | claimed |
| WO-2016029185-A1 | BALLAST WATER TREATMENT SYSTEMS | COATING SYSTEMS LABORATORIES, INC. (US) | 2016-02-25 | — | — | WO | claimed |
| US-20150360155-A1 | Ballast Water Treatment Systems | BERMAN, RENEE | 2015-12-17 | — | — | US | claimed |
| WO-2015042268-A1 | CORE AND SURFACE MODIFICATION OF MESOPOROUS SILICA NANOPARTICLES TO ACHIEVE CELL SPECIFIC TARGETING IN VIVO | STC.UNM (US) | 2015-03-26 | — | — | WO | claimed |
| US-8178119-B2 | Zinc pyrithione, triclosan, polymeric binder, fluorocarbon hydrophobicizing agent; against colonization by house dust mites; mattress ticking, furniture covering fabrics and carpets | SANITIZED AG (CH) | 2012-05-15 | — | — | US | claimed |
| US-20080260860-A1 | Method for the Acaricidal Finishing of Textile Materials | SANITIZED AG (CH) | 2008-10-23 | — | — | US | claimed |
| US-20250304605-A1 | ANTIMICROBIAL ORGANOSILANES | TOPIKOS SCIENTIFIC, INC. (US) | 2025-10-02 | — | — | US | disclosed |
| US-12264170-B2 | Antimicrobial organosilanes | TOPIKOS SCIENTIFIC, INC. (US) | 2025-04-01 | — | — | US | disclosed |
| US-12134628-B2 | Antimicrobial organosilanes | TOPIKOS SCIENTIFIC, INC. | 2024-11-05 | — | — | US | disclosed |
| US-20240309026-A1 | ANTIMICROBIAL ORGANOSILANES | TOPIKOS SCIENTIFIC, INC. (US) | 2024-09-19 | — | — | US | disclosed |
| US-4845256-A | Production of silyl quaternary ammonium compounds | SANITIZED AG (CH) | 1989-07-04 | — | — | US | disclosed |
| EP-0108853-B1 | 3-(TRIMETHOXYSILYL)PROPYLDIDECYLMETHYL AMMONIUM SALTS AND METHOD OF INHIBITING GROWTH OF MICROORGANISMS THEREWITH | Klein, Stewart E. (US) | 1986-02-26 | — | — | EP | disclosed |
| EP-0108853-A1 | 3-(Trimethoxysilyl)propyldidecylmethyl ammonium salts and method of inhibiting growth of microorganisms therewith | Klein, Stewart E. (US) | 1984-05-23 | — | — | EP | disclosed |
| US-4394378-A | BACTERICIDES, FUNGICIDES | CARAGEST/A.G. (CH) | 1983-07-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250304605-A1 | ANTIMICROBIAL ORGANOSILANES | ARG1, ACMSD, AAAS | SIGMAR1 1107/4885LMNA 4596/4885ZDHHC7 3392/4885 |
| US-12264170-B2 | Antimicrobial organosilanes | ARG1, ACMSD, AAAS | SIGMAR1 1107/4885LMNA 4596/4885ZDHHC7 3392/4885 |
| US-20240309026-A1 | ANTIMICROBIAL ORGANOSILANES | ARG1, ACMSD, AAAS | SIGMAR1 1107/4885LMNA 4596/4885ZDHHC7 3392/4885 |
| US-12134628-B2 | Antimicrobial organosilanes | ARG1, ACMSD, AAAS | SIGMAR1 1107/4885LMNA 4596/4885ZDHHC7 3392/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.